1. 2c. POSITION TITLE 2d. PRINCIPAL INVESTIGATOR’S MAILING ADDRESS (Street, city, zip code) 2e. DIVISION 2f. DEPARTMENT, SERVICE, LABORATORY, OR EQUIVALENT E-MAIL ADDRESS: 2g. TELEPHONE AND FAX (Area code, number and extension) TEL: FAX: 3. CO-INVESTIGATOR (listed below) 3a. NAME (Last, first, middle) 3b. DEGREE(S) 1. 1. 1. 1. 2. 2. 2. 2. 3. 3. 3. 3. 4. 4. 4. 4. 5. 5. 5. 5. 3c. POSITION TITLE 3d. MAILING ADDRESS (Street, city, state, zip code) 1. 1. 2. 2. 3. 3. 4. 4. 5. 5. 3e. DIVISION 1. 2. 3. 4. 5. 3f. DEPARTMENT, SERVICE, LABORATORY, OR EQUIVALENT 1. 2. 3. 4. 5. 3g. TELEPHONE AND FAX (Area code, number and extension) E-MAIL ADDRESS: 1. TEL: FAX: 1. 2. 1. 1. 2. 3. 2. 2. 3. 4. 3. 3. 4. 5. 4. 4. 5. 5. 5. 4. Human Subjects Research 4a. Research Exempt 4b. Human Subjects Assurance No. 5. Human Subjects No Yes No Yes Protection Certification: If Exemption 4c. NIH-Defined Phase I Clinical No Yes “Yes,” No. 5a. Certification Date: No Yes 6. Vertebrate Animals 7. IBC Protocol 8. Radiation No Yes No Yes No Yes 6a. If IACUC Approval 7a. If Approval Date: “Yes,” “Yes,” Date 8a. If Approval “Yes,” 7b. Approval Number: Date 6b. Animal Welfare Assurance No. REQUESTED 9. DATES OF PROPOSED PERIOD OF Direct ($) SUPPORT (month, day, year—MM/DD/YY) From Through 03/31/2017 04/1/2018
1. 2c. POSITION TITLE 2d. PRINCIPAL INVESTIGATOR’S MAILING ADDRESS (Street, city, zip code) 2e. DIVISION 2f. DEPARTMENT, SERVICE, LABORATORY, OR EQUIVALENT 2g. TELEPHONE AND FAX (Area code, number and extension) E-MAIL ADDRESS: TEL: FAX: 3. CO-INVESTIGATOR (listed below) 3a. NAME (Last, first, middle) 1. 2. 3. 4. 5. 3b. DEGREE(S) 1. 2. 3. 4. 5. 1. 2. 3. 4. 5. 1. 2. 3. 4. 5. 3c. POSITION TITLE 1. 2. 3. 4. 5. 3d. MAILING ADDRESS (Street, city, state, zip code) 1. 2. 3. 4. 5. 3e. DIVISION 1. 2. 3. 4. 5. 3f. DEPARTMENT, SERVICE, LABORATORY, OR EQUIVALENT 1. 2. 3. 4. 5. 3g. TELEPHONE AND FAX (Area code, number and extension) E-MAIL ADDRESS: 1. 2. 3. 4. 5. TEL: 1. 2. 3. 4. 5. FAX: 1. 2. 3. 4. 5. 1. 2. 3. 4. 5. 4. Human Subjects Research No Yes 4a. Research Exempt No Yes If “Yes,” Exemption No. 4b. Human Subjects Assurance No. 4c. NIH-Defined Phase I Clinical No Yes 5. Human Subjects Protection Certification: No Yes 5a. Certification Date: 6. Vertebrate Animals No Yes 6a. If “Yes,” IACUC Approval Date 6b. Animal Welfare Assurance No. 7. IBC Protocol No Yes 7a. If “Yes,” Approval Date: 7b. Approval Number: 8. Radiation No Yes 8a. If “Yes,” Approval Date 9. DATES OF PROPOSED PERIOD OF SUPPORT (month, day, year—MM/DD/YY) REQUESTED Direct ($) From Through 03/31/2017 04/1/2018